ATXS
Price
$6.18
Change
-$0.35 (-5.36%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
368.52M
75 days until earnings call
IKT
Price
$1.79
Change
-$0.05 (-2.72%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
134.13M
Interact to see
Advertisement

ATXS vs IKT

Header iconATXS vs IKT Comparison
Open Charts ATXS vs IKTBanner chart's image
Astria Therapeutics
Price$6.18
Change-$0.35 (-5.36%)
Volume$4.79K
Capitalization368.52M
Inhibikase Therapeutics
Price$1.79
Change-$0.05 (-2.72%)
Volume$2.96K
Capitalization134.13M
ATXS vs IKT Comparison Chart in %
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. IKT commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Hold and IKT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (ATXS: $6.53 vs. IKT: $1.84)
Brand notoriety: ATXS and IKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 85% vs. IKT: 23%
Market capitalization -- ATXS: $368.52M vs. IKT: $137.11M
ATXS [@Biotechnology] is valued at $368.52M. IKT’s [@Biotechnology] market capitalization is $137.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileIKT’s FA Score has 1 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • IKT’s FA Score: 1 green, 4 red.
According to our system of comparison, IKT is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 4 TA indicator(s) are bullish while IKT’s TA Score has 6 bullish TA indicator(s).

  • ATXS’s TA Score: 4 bullish, 3 bearish.
  • IKT’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, IKT is a better buy in the short-term than ATXS.

Price Growth

ATXS (@Biotechnology) experienced а +2.83% price change this week, while IKT (@Biotechnology) price change was +9.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.74%. For the same industry, the average monthly price growth was +15.52%, and the average quarterly price growth was +29.97%.

Reported Earning Dates

ATXS is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (-0.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($369M) has a higher market cap than IKT($134M). ATXS YTD gains are higher at: -26.957 vs. IKT (-43.385). IKT has higher annual earnings (EBITDA): -45.66M vs. ATXS (-131.42M). ATXS has more cash in the bank: 259M vs. IKT (87.7M). IKT has less debt than ATXS: IKT (37.9K) vs ATXS (4.77M). ATXS (0) and IKT (0) have equivalent revenues.
ATXSIKTATXS / IKT
Capitalization369M134M275%
EBITDA-131.42M-45.66M288%
Gain YTD-26.957-43.38562%
P/E RatioN/AN/A-
Revenue00-
Total Cash259M87.7M295%
Total Debt4.77M37.9K12,575%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSIKT
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 18 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TIMCF0.960.04
+3.90%
Titan Mining Corporation
XIACF6.870.07
+1.03%
Xiaomi Corp.
KIGRY16.440.12
+0.74%
KION GROUP AG
GRRMY13.19N/A
N/A
Gerresheimer AG
CWBHF0.09N/A
-1.66%
Charlotte's Web Holdings Inc.

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with XENE. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
+0.31%
XENE - ATXS
52%
Loosely correlated
-0.69%
CRNX - ATXS
52%
Loosely correlated
+0.82%
NRIX - ATXS
51%
Loosely correlated
-1.47%
DNLI - ATXS
50%
Loosely correlated
+0.32%
COGT - ATXS
49%
Loosely correlated
-2.34%
More

IKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IKT has been loosely correlated with SYRE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if IKT jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
+2.79%
SYRE - IKT
36%
Loosely correlated
-2.45%
CGON - IKT
34%
Loosely correlated
+0.89%
CRNX - IKT
33%
Loosely correlated
+0.82%
ARWR - IKT
33%
Loosely correlated
+2.52%
ATXS - IKT
32%
Poorly correlated
+0.31%
More